APA

Monsma D. J., Cherba D. M., Eugster E. E., Dylewski D. L., Davidson P. T., Peterson C. A., Borgman A. S., Winn M. E., Dykema K. J., Webb C. P., MacKeigan J. P., Duesbery N. S., Nickoloff B. J. & Monks N. R. (20150623). Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms. : American journal of cancer research.

Chicago

Monsma David J, Cherba David M, Eugster Emily E, Dylewski Dawna L, Davidson Paula T, Peterson Chelsea A, Borgman Andrew S, Winn Mary E, Dykema Karl J, Webb Craig P, MacKeigan Jeffrey P, Duesbery Nicholas S, Nickoloff Brian J and Monks Noel R. 20150623. Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms. : American journal of cancer research.

Harvard

Monsma D. J., Cherba D. M., Eugster E. E., Dylewski D. L., Davidson P. T., Peterson C. A., Borgman A. S., Winn M. E., Dykema K. J., Webb C. P., MacKeigan J. P., Duesbery N. S., Nickoloff B. J. and Monks N. R. (20150623). Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms. : American journal of cancer research.

MLA

Monsma David J, Cherba David M, Eugster Emily E, Dylewski Dawna L, Davidson Paula T, Peterson Chelsea A, Borgman Andrew S, Winn Mary E, Dykema Karl J, Webb Craig P, MacKeigan Jeffrey P, Duesbery Nicholas S, Nickoloff Brian J and Monks Noel R. Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms. : American journal of cancer research. 20150623.